Our studies also revealed CoV-specific effects of IFN response on disease outcomes, as demonstrated by the detrimental role of IFNs during SARS-CoV infection and, in contrast, a protective effect during mouse-CoV, MERS-CoV, and SARS-CoV-2 infection (28, 44, 46). The gene discussed is IFNA1; the disease is severe acute respiratory syndrome.